Abstract:In present, there was no detailed report on the formulation optimization and quality evaluation of aprepitant (APT) injectable lipid emulsion (APT-IE). The aim of the present investigation was to prepare and evaluate its properties of APT-IE loaded with an APT phospholipid complex (APT-PC) in vitro and in vivo . APT-PC was obtained by solvent evaporation with APT and phospholipids, then analyzed by X -ray diffraction, Fourier transform infrared spectroscopy and differential scanning calorimetry. Lipid emulsions are a new formulation that can reduce side effects and improve drug loading. APT-IE prepared by High-pressure homogenization and optimized by response surface methodology (RSM). The proportion of sodium oleate, poloxamer 188 and soybean oil were selected as variables for the optimization. The optimal formulation of ATP-IE had the following characteristics: particle size, 82.83 ± 1.89 nm; polydispersity index, 0.243 ± 0.008; zeta potential, −59.0 ± 2.54 mV; encapsulation efficiency, 98.84%±1.43%; drug loading, 7.08 ± 0.16 mg/mL; and osmotic pressure, 301 ± 2.15 mOsmol/kg. Transmission electron microscopy images indicated that the particle diameter of APT-IE was approximately 100 nm, with a morphology of spheroidal or spherical. APT-IE exhibited sufficient stability after storage at 4 ± 2 °C for more than 6 months. The results of the pharmacokinetic study demonstrated that APT-IE had the advantages of better safety, higher bioavailability, and obvious liver targeting than APT solution (APT-SL). The area under the curve (AUC) of APT-IE was 3-fold enhanced compared with APT-SL. The targeted enhancement multiple of APT-IE to liver tissue was greater than that of APT-SL. These results suggested that APT-IE has broad clinical application and industrial production potential.

Recent Development of Drug-loaded Intravenous Lipid Emulsions

Advances in intravenous lipid emulsions

[Recent Advances in Liposomes and Nanoparticles As Drug Carriers for Drug Delivery].

Liposome: composition, characterisation, preparation, and recent innovation in clinical applications

A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives

Fundamental Aspects of Lipid-Based Excipients in Lipid-Based Product Development

Progress of Liposome as Drug Carriers

Exploring lipids: A comprehensive review on their utilization in the formulation of liposomes, phytosomes, and ethosomes for advanced drug delivery systems"

Preparation and in vivo evaluation of an intravenous emulsion loaded with an aprepitant-phospholipid complex

Development of Emulsion Gels for the Delivery of Functional Food Ingredients: from Structure to Functionality

Transforming lipid-based oral drug delivery systems into solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance

Recent progresses of exosome–liposome fusions in drug delivery

Advancements in lipid-based delivery systems for functional foods: a comprehensive review of literature and patent trends

Application of Lipid Nanoparticles As Oral Drug Delivery System

Lipid-Based Nanoformulations for Drug Delivery: An Ongoing Perspective

Recent Advances in Protein-Based Multilayer Emulsions: Fabrication, Characterization, and Applications: A Review

Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers

Recent patents on nonlamellar liquid crystalline lipid phases in drug delivery

Preparation and Characterization of Drug-Loaded Lipid Nanoparticles

Fabrication and Characterizations of a Novel Drug Delivery Device Liposomes-in-microsphere (LIM).

Recent Advances in the Development of Liquid Crystalline Nanoparticles as Drug Delivery Systems